CD4 and hepatocellular carcinoma: Overall, interactions among TAMs, TANs, MDSCs, Tregs, CTLs, CD4+ T cell subsets, B cells, and malignant hepatocytes drive changes in the hepatic immune landscape, leading to a predominantly immunosuppressive environment that supports HCC development and progression (80).